Evado launches into Asia

By Staff Writers
Wednesday, 22 October, 2008

Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.

Evado is being distributed by local clinical research company SeerPharma.

Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.

It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.

Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.

Related News

Overuse of inhalers can increase heart attack risk

Overuse of reliever inhalers is associated with higher risks of developing and dying from...

Unhealthy Western diet could accelerate cognitive decline

An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...

Cancer drug enters clinical trials based on a false mechanism

A cancer drug currently being tested in patients appears to have entered clinical trials based on...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd